Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

NHS risks missing out on independent prescriber benefits

 April 9, 2026

Pharmaphorum

Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.

Policy / PricingRead full story

Post navigation

Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors →
← Roche sticks with C4T, adding up to $1B for molecular glue partnership

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com